| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Sep 1, 2026 | Disposed to issuer(D) | 248K | $85.00 | $21.1M | 177K |
| Sep 1, 2026 | Disposed to issuer(D) | 1K | $85.00 | $85K | 0 |
| Sep 1, 2026 | Disposed to issuer(D) | 137K | $85.00 | $11.6M | 0 |
| Sep 1, 2026 | Disposed to issuer(D) | 106K | $85.00 | $9.0M | 0 |
| Sep 1, 2026 | Disposed to issuer(D) | 110K | $85.00 | $9.3M | 0 |
| Sep 1, 2026 | Disposed to issuer(D) | 100K | $85.00 | $8.5M | 0 |
| Sep 1, 2026 | Disposed to issuer(D) | 111K | $85.00 | $9.4M | 0 |
| Sep 1, 2026 | Disposed to issuer(D) | 111K | $85.00 | $9.4M | 0 |
| Sep 1, 2026 | Disposed to issuer(D) | 111K | $85.00 | $9.4M | 0 |
| Sep 1, 2026 | Disposed to issuer(D) | 111K | $85.00 | $9.4M | 0 |
| Sep 1, 2026 | Disposed to issuer(D) | 80K | $85.00 | $6.8M | 0 |
| Sep 1, 2026 | Disposed to issuer(D) | 177K | $85.00 | $15.0M | 0 |
| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Sep 1, 2026 | Disposed to issuer(D) | 172K | $59.81 | $10.3M | 0 |
| Sep 1, 2026 | Disposed to issuer(D) | 196K | $62.39 | $12.2M | 0 |
| Sep 1, 2026 | Disposed to issuer(D) | 259K | $69.71 | $18.1M | 0 |
| Sep 1, 2026 | Disposed to issuer(D) | 244K | $64.98 | $15.9M | 0 |
| Sep 1, 2026 | Disposed to issuer(D) | 288K | $65.36 | $18.8M | 0 |
| Sep 1, 2026 | Disposed to issuer(D) | 240K | $41.49 | $10.0M | 0 |
| Sep 1, 2026 | Disposed to issuer(D) | 313K | $48.14 | $15.1M | 0 |
| Sep 1, 2026 | Disposed to issuer(D) | 228K | $41.21 | $9.4M | 0 |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-059882) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Crinetics Pharmaceuticals, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.